Clinical Trials Directory

Trials / Unknown

UnknownNCT03404856

Study of ORL-1G (D-galactose) in Patients With Glycogen Storage Disease Type 14

Status
Unknown
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
5 (estimated)
Sponsor
Orpha Labs · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Study of ORL-1G in Patients With Glycogen Storage Disease Type 14

Conditions

Interventions

TypeNameDescription
DRUGORL-1G - D-galactoseOral ORL-1G - D-galactose

Timeline

Start date
2017-10-31
Primary completion
2019-10-31
Completion
2019-10-31
First posted
2018-01-19
Last updated
2019-01-25

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT03404856. Inclusion in this directory is not an endorsement.

Study of ORL-1G (D-galactose) in Patients With Glycogen Storage Disease Type 14 (NCT03404856) · Clinical Trials Directory